DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-74,489

WARNER CHILCOTT PHARMACEUTICALS, INC.
INCLUDING ON-SITE LEASED WORKERS FROM
ADECCO ENGINEERING AND TECHNICAL
NORWICH, NEW YORK

Amended Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor issued
a Certification of Eligibility to Apply for Worker Adjustment
Assistance on September 10, 2010, applicable to workers of Warner
Chilcott Pharmaceuticals, Inc., Norwich, New York. The notice
was published in the Federal Register on September 23, 2010 (75
FR 57982).
At the request of a petitioner, the Department reviewed the
certification for workers of the subject firm. The workers were
engaged in employment related to the supply of pharmaceutical
research and development services.
The company reports that workers leased from Adecco
Engineering and Technical were employed on-site at the Norwich,
New York location of Warner Chilcott Pharmaceuticals, Inc. The
Department has determined that these workers were sufficiently
under the control of the subject firm to be considered leased
workers.
Based on these findings, the Department is amending this
certification to include workers leased from Adecco Engineering
and Technical working on-site at the Norwich, New York location
of Warner Chilcott Pharmaceuticals, Inc.
The amended notice applicable to TA-W-74,489 is hereby
issued as follows:
"All workers of Warner Chilcott Pharmaceuticals, Inc.,
including on-site leased workers from Adecco
Engineering and Technical, Norwich, New York, who
became totally or partially separated from employment
on or after August 6, 2009, through September 10, 2012,
and all workers in the group threatened with total or
partial separation from employment on the date of
certification through two years from the date of
certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act
of 1974, as amended.”
Signed at Washington, D.C. this 8th day of October 2010.

/s/ Elliott S. Kushner
__________________________________
ELLIOTT S. KUSHNER
Certifying Officer, Division
of Trade Adjustment Assistance

4510-FN-P


DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-74,489

WARNER CHILCOTT PHARMACEUTICALS, INC.
NORWICH, NEW YORK

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor herein
presents the results of an investigation regarding certification of
eligibility to apply for worker adjustment assistance.
The group eligibility requirements for workers of a firm under
Section 222(a) of the Act, 19 U.S.C. § 2272(a), are satisfied if
the following criteria are met:
I. The first criterion (set forth in Section 222(a)(1) of the
Act, 19 U.S.C. § 2272(a)(1)) requires that a significant
number or proportion of the workers in the workers’ firm must
have become totally or partially separated or be threatened
with total or partial separation.

II. The second criterion (set forth in Section 222(a)(2) of the
Act, 19 U.S.C. § 2272(a)(2)) may be satisfied if either:

(i)(I) there has been a shift by the workers’ firm to a
foreign country in the production of articles or supply
of services like or directly competitive with those
produced/supplied by the workers’ firm; OR
(i)(II) there has been an acquisition from a foreign country
by the workers’ firm of articles/services that are like
or directly competitive with those produced/supplied by
the workers’ firm.

III. The third criterion requires that the shift/acquisition must
have contributed importantly to the workers’ separation or
threat of separation. See Section 222(a)(2)(B)(ii) of the
Act, 19 U.S.C. § 2272(a)(2)(B)(ii).

The investigation was initiated in response to a petition
filed on August 6, 2010 on behalf of workers of Warner Chilcott
Pharmaceuticals, Inc., Norwich, New York (Warner Chilcott). The
workers were engaged in employment related to the supply of
pharmaceutical research and development services.
The investigation revealed that workers of Warner Chilcott
who are engaged in employment related to the supply of
pharmaceutical research and development services meet the
criteria for certification.
Criterion I has been met because a significant number or
proportion of the workers became separated during the relevant
period.
Criterion II has been satisfied because the subject firm
shifted to a foreign country the supply of a service like or
directly competitive with the service supplied by the workers.
Criterion III has been met because the shift of supply of
pharmaceutical research and development services to Ireland and
the United Kingdom by Warner Chilcott contributed importantly to
worker group separations at Warner Chilcott.


Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Warner Chilcott
Pharmaceuticals, Inc., Norwich, New York, who are engaged in
employment related to the supply of pharmaceutical research and
development services meet the worker group certification criteria
under Section 222(a) of the Act, 19 U.S.C. § 2272(a). In accordance
with Section 223 of the Act, 19 U.S.C. § 2273, I make the following
certification:
“All workers of Warner Chilcott Pharmaceuticals, Inc.,
Norwich, New York, who became totally or partially separated
from employment on or after August 6, 2009, through two years
from the date of certification, and all workers in the group
threatened with total or partial separation from employment on
date of certification through two years from the date of
certification, are eligible to apply for adjustment assistance
under Chapter 2 of Title II of the Trade Act of 1974, as
amended.”
Signed in Washington, D.C., this 10th day of September, 2010.


/s/Elliott S. Kushner
______________________________
ELLIOTT S. KUSHNER
Certifying Officer, Office of
Trade Adjustment Assistance



- 5 -